Financial results - NEURO REVIEW S.R.L.

Financial Summary - Neuro Review S.r.l.
Unique identification code: 42475870
Registration number: J12/1221/2020
Nace: 8621
Sales - Ron
88.219
Net Profit - Ron
22.629
Employees
2
Open Account
Company Neuro Review S.r.l. with Fiscal Code 42475870 recorded a turnover of 2024 of 88.219, with a net profit of 22.629 and having an average number of employees of 2. The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Neuro Review S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 6.434 44.111 51.956 71.893 88.219
Total Income - EUR - - - - - 6.434 44.111 51.956 71.894 88.538
Total Expenses - EUR - - - - - 9.098 36.525 44.814 48.843 63.799
Gross Profit/Loss - EUR - - - - - -2.664 7.586 7.142 23.050 24.740
Net Profit/Loss - EUR - - - - - -2.672 6.395 6.505 22.368 22.629
Employees - - - - - 1 1 1 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 23.4%, from 71.893 euro in the year 2023, to 88.219 euro in 2024. The Net Profit increased by 386 euro, from 22.368 euro in 2023, to 22.629 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Neuro Review S.r.l.

Rating financiar

Financial Rating -
NEURO REVIEW S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Neuro Review S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neuro Review S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Neuro Review S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neuro Review S.r.l. - CUI 42475870

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 12.257 20.991 17.114 13.133 25.701
Current Assets - - - - - 3.904 6.741 7.288 24.368 35.489
Inventories - - - - - 2.854 5.000 4.436 0 0
Receivables - - - - - 252 469 2.510 22.223 30.416
Cash - - - - - 798 1.271 342 2.144 5.072
Shareholders Funds - - - - - -2.631 3.822 6.568 22.416 30.732
Social Capital - - - - - 41 40 41 40 40
Debts - - - - - 18.994 23.978 17.889 15.118 30.458
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 35.489 euro in 2024 which includes Inventories of 0 euro, Receivables of 30.416 euro and cash availability of 5.072 euro.
The company's Equity was valued at 30.732 euro, while total Liabilities amounted to 30.458 euro. Equity increased by 8.442 euro, from 22.416 euro in 2023, to 30.732 in 2024.

Risk Reports Prices

Reviews - Neuro Review S.r.l.

Comments - Neuro Review S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.